Sagimet Biosciences Inc-A SGMT

Name: Sagimet Biosciences Inc-A
SKU: SGMT
Price: 5.64 USD
Availability: InStock

‎$‎5.640.19(3.49%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Price Target

28.20

Based on analysts who covered SGMT

Invest in Sagimet Biosciences Inc-A
Today

Create an eToro account to buy SGMT stock on a secure, user-friendly, multi-asset trading platform.

Sagimet Biosciences Inc-A SGMT

Buy SGMT

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

OSW

OneSpaWorld Holdings Limited

MAX

*Past performance is not an indication of future results

Jump to:

About SGMT >
How to Buy? >
Top Guides >

The Sagimet Biosciences Inc-A share price is on the decline this week.

The Sagimet Biosciences Inc-A share price today is ‎$‎5.64, reflecting a ‎3.49‎% change over the last 24 hours and ‎-7.07‎% over the past week. The current market capitalization of SGMT is ‎$‎177.24M with an average volume in the last three months of 653048.32. The stock has a P/E ratio of -3.05 and a dividend yield of 0%. With the stock’s beta sitting at 0

SGMT Key Metrics

Market Cap

‎$‎177.24M

Day’s Range

‎$‎5.31 - ‎$‎5.7

52W Range

‎$‎1.69 - ‎$‎11.36

Average Volume (3M)

653048.32

Price-Earnings Ratio

-3.05

Revenue

‎$‎0

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎5.64

EPS

‎$‎-1.79

Beta

How can I buy Sagimet Biosciences Inc-A stocks?

To purchase Sagimet Biosciences Inc-A:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Sagimet Biosciences Inc-A (SGMT) page and place an order to buy Sagimet Biosciences Inc-A.

Buy SGMT

Looking for more information? Check out our guide on Academy.

What Is Sagimet Biosciences Inc-A?

Sagimet Biosciences, Inc. - Class A is a biopharmaceutical company that develops novel therapeutics for treating metabolic disorders, certain cancers, and acne. Its operations traverse various regional markets, exploring the connection between chronic liver diseases and metabolic activities.

As a part of the biotechnology industry, Sagimet Biosciences specialises in finding solutions for chronic liver diseases, such as non-alcoholic steatohepatitis (NASH) and hepatitis B. The company has numerous clinical-stage drug candidates into its portfolio.

Stay up to date on the share price of SGMT by adding it to your eToro watchlist.

CEO

David A. Happel, MBA

Employees

Founded

2006

San Mateo, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Sagimet Biosciences Inc-A
Today

Create an eToro account to buy SGMT stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Sagimet Biosciences Inc-A stock?

The current price of SGMT is ‎$‎5.64.

What is Sagimet Biosciences Inc-A’s stock future price target?

The average price target for Sagimet Biosciences Inc-A is ‎$‎28.20. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Sagimet Biosciences Inc-A?

Analysts offer forecasts for Sagimet Biosciences Inc-A based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Sagimet Biosciences Inc-A?

The market capitalisation of Sagimet Biosciences Inc-A is ‎$‎177.24M

Is Sagimet Biosciences Inc-A stock buy, sell or hold?

Based on 5 analysts offering recommendations for SGMT in the last 3 months, the overall consensus is .

Daily Movers

Explore the biggest stocks movers on the market.